Search - tctmd.com

Displaying 61 - 80 of 1228

Sort: Relevancy | Date

Presentation TCT 2024

The Cath Lab Glass Ceiling: Radiation Exposure and Gender Disparity

Presenter: Megan Coylewright

October 28, 2024

Presentation TCT 2024

The Weight of a Lifetime of Lead: My Personal Journey Through Radiation Exposure

Presenter: Dean Kereiakes

October 28, 2024

Presentation TCT 2024

FDA Perspective

Presenter: Misti Malone

October 28, 2024

Presentation TCT 2024

Industry Perspective

Presenter: Kazuhisa Senshu

October 28, 2024

Presentation TCT 2024

PMDA/MHLW Perspective

Presenter: Erika Noro

October 28, 2024

Presentation TCT 2024

Academic Perspective: Twenty-One Years of HBD: How Far We Reached

Presenter: Shigeru Saito

October 28, 2024

News Conference News TCT 2024

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

L.A. McKeown

October 27, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

Todd Neale

October 27, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

Presentation TCT 2024

Patient Reported Outcomes in National Registries: Why and How?

Presenter: Joan Michaels

October 27, 2024

Presentation TCT 2024

Shared Decision-Making: A Toolkit for the Heart Team

Presenter: Megan Coylewright

October 27, 2024

Presentation TCT 2024

Closing the Gap Between Good Intentions and Implementation

Presenter: Sandra Lauck

October 27, 2024

Presentation TCT 2024

TCT 304: SGLT2 Inhibitor Empagliflozin Before Coronary Angiography: Can We Reduce Patient Stress?

Presenter: Katica Cvitkusic Lukenda

October 27, 2024

Presentation TCT 2024

TCT 745: Real-World Reductions in Lead-Free Radiation Exposure With the Rampart System During Endovascular Procedures

Presenter: Matthew Herzig

October 27, 2024

Presentation TCT 2024

TCT 305: Complex High-Risk Indicated PCI (CHIP-PCI): Is It Safe to Let Fellows-in-Training Perform It as Primary Operators?

Presenter: Majd Protty

October 27, 2024

Presentation TCT 2024

TCT 303: Fasting Versus Non-Fasting Approach Before Invasive Coronary Procedures: A Systematic Review and Meta-Analysis

Presenter: Prakash Upreti

October 27, 2024

Presentation TCT 2024

TCT 746: Reduction of Primary Operator Radiation Dose With Portable Radiation Shielding and Real-Time Dosimetry Monitoring

Presenter: Christine Shen

October 27, 2024

Presentation TCT 2024

Animal Study Considerations

Presenter: Natalie Miller

October 27, 2024

Presentation TCT 2024

Biocompatibility Evaluation Considerations

Presenter: Girish Kumar

October 27, 2024

Advertisement

The Cath Lab Glass Ceiling: Radiation Exposure and Gender Disparity

The Weight of a Lifetime of Lead: My Personal Journey Through Radiation Exposure

FDA Perspective

Industry Perspective

PMDA/MHLW Perspective

Academic Perspective: Twenty-One Years of HBD: How Far We Reached

Radiation Survey Reveals Variable Practices as Operators Look to Themselves for Fixes

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

LAAO Outcomes Similar Regardless of Operator’s Specialty

Safety Retained When Fellows Lead Complex PCI Procedures

Patient Reported Outcomes in National Registries: Why and How?

Shared Decision-Making: A Toolkit for the Heart Team

Closing the Gap Between Good Intentions and Implementation

TCT 304: SGLT2 Inhibitor Empagliflozin Before Coronary Angiography: Can We Reduce Patient Stress?

TCT 745: Real-World Reductions in Lead-Free Radiation Exposure With the Rampart System During Endovascular Procedures

TCT 305: Complex High-Risk Indicated PCI (CHIP-PCI): Is It Safe to Let Fellows-in-Training Perform It as Primary Operators?

TCT 303: Fasting Versus Non-Fasting Approach Before Invasive Coronary Procedures: A Systematic Review and Meta-Analysis

TCT 746: Reduction of Primary Operator Radiation Dose With Portable Radiation Shielding and Real-Time Dosimetry Monitoring

Animal Study Considerations

Biocompatibility Evaluation Considerations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content